Finnrick, an independent testing programme, publishes 29 assays for Tianjin Eleli Technology Development: 16 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 13 did not. Most recent assay 15 Jul 2026.
Tianjin Eleli Technology Development operates from China, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/tianjin-eleli-technology-development.
Finnrick-tested with very poor results. Tested across 1 peptide products with 7 total samples.
Tianjin Eleli Technology Development is listed as active. Finnrick Grade E. Finnrick avg score: 6.5/10 across 7 samples (1 products). Poor quality detected in testing. Use with extreme caution.
Tianjin Eleli Technology Development holds independent lab grade E, assigned across 7 graded samples, average score 6.5/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
No independent third-party assay is on file for Tianjin Eleli Technology Development, and we have not yet compiled a profile of its own website. An untested vendor has not failed a test — this is an absence of evidence, not evidence against it.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 15 | 11 passed, 4 failed |
| GHK-Cu | 5 | 2 passed, 3 failed |
| Tirzepatide | 5 | 1 passed, 4 failed |
| Tesamorelin | 4 | 2 passed, 2 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | E (7 samples) |
| Average grader score | 6.5/10 |
| Vendor type | Research-use supplier |
| Satisfaction | 0.4/5 |
|---|---|
| Delivery | 4.6/5 |
| Customer service | 4.8/5 |
| Packaging | 4.6/5 |
| Ease of purchase | 5/5 |
| Payment | 5/5 |
Scored out of 5 by the same independent grader, from its own buyers rather than from this site.
Tianjin Eleli Technology Development is listed as active and we hold 29 Finnrick assays (16 passing, 13 failing its purity threshold); an independent lab grade of E. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 29 assays for Tianjin Eleli Technology Development: 16 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 13 did not. Most recent assay 15 Jul 2026.
Similar vendors: Modern Aminos, Shanxi Qianyecao Biotech QYC, Mix Peptides, Xian Yihang Technology, Zhuoyue Biotechnology, Haikou Mingheng Biotechnology, Alimo Peptide, Peptides For Sale.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Tianjin Finder Chemical TFC Peptides Review, Tianjin Ruiwang New Material Technology Co Peptides Review, Tide Labs Peptides Review.